Home NDC 10056-701 Peter Island Continuous Sport Sunscreen
Product NDC 10056-701
11-digit product format 100560701
Labeler code 10056
Product ID 10056-701_17e0c695-9b3b-4059-b74b-699f976ebc85
Type HUMAN OTC DRUG
Nonproprietary name HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE
Dosage form SPRAY
Route TOPICAL
Labeler Access Business Group LLC
Application part352
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2013-06-27
Marketing end 0000-00-00
Substance HOMOSALATE; OXYBENZONE; AVOBENZONE; OCTISALATE; OCTOCRYLENE
Active strength 15 g/100g; g/100g; g/100g; g/100g; g/100g
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 10056-701-34 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 10056-701-34 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 10056-701-34 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 10056-701-34 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 10056-701-34 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 10056-701-34 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 10056-701-34 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 10056-701-34 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 10056-701-34 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 10056-701-34 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 10056-701-34 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 10056-701-34 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 10056-701-34 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 10056-701-34 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 10056-701-34 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 10056-701-34 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 10056-701-34 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 10056-701-34 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 10056-701-34 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 10056-701-34 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 10056-701-34 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 10056-701-34 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 10056-701-34 Peter Island Continuous Sport SunscreenSPF 50 170 g in 1 BOTTLE, PLASTIC SPRAY 170 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded AVOBENZONE ACTIVE INGREDIENT G63QQF2NOX PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 HOMOSALATE ACTIVE INGREDIENT V06SV4M95S PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 OCTISALATE ACTIVE INGREDIENT 4X49Y0596W PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 OCTOCRYLENE ACTIVE INGREDIENT 5A68WGF6WM PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 OXYBENZONE ACTIVE INGREDIENT 95OOS7VE0Y PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 AVOBENZONE ACTIVE MOIETY G63QQF2NOX PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 HOMOSALATE ACTIVE MOIETY V06SV4M95S PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 OCTISALATE ACTIVE MOIETY 4X49Y0596W PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 OCTOCRYLENE ACTIVE MOIETY 5A68WGF6WM PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 OXYBENZONE ACTIVE MOIETY 95OOS7VE0Y PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 ALOE VERA LEAF INACTIVE INGREDIENT ZY81Z83H0X PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 COCONUT OIL INACTIVE INGREDIENT Q9L0O73W7L PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 MINERAL OIL INACTIVE INGREDIENT T5L8T28FGP PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 WATER INACTIVE INGREDIENT 059QF0KO0R PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 10056-701 PETER ISLAND CONTINUOUS SPORT SUNSCREEN SPF 50 (HOMOSALATE, OXYBENZONE, OCTISALATE, AVOBENZONE, OCTOCRYLENE) SPRAY [ACCESS BUSINESS GROUP LLC] 1 Legacy NDC, 1 package rows 20130628_e932b6a3-91a8-4bd9-bfb4-76f29f403af4.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 10056-701-34 10056070134 170 g in 1 BOTTLE, PLASTIC 170 g Historical